You are here

Lupkynis

Why Aurinia Pharmaceuticals Tumbled Despite Its 'Aggressive' 2022 Outlook

Investors Business Daily

Thu, 03/3/22 - 11:36 pm

Aurinia Pharmaceuticals

As GSK, Aurinia heat up the lupus nephritis category, analyst gauges doctors' first impressions

Fierce Pharma

Thu, 06/24/21 - 11:11 am

lupus nephritis

Catalent signs on to produce Aurinia's newly approved lupus nephritis drug

Fierce Pharma

Mon, 02/22/21 - 10:46 am

Aurinia Pharmaceuticals

lupus nephritis

Here’s Why the Approval of Lupkynis Has Biotech Investors Buzzing

Xtalks

Mon, 02/1/21 - 10:52 am

Aurinia Pharmaceuticals

lupus nephritis

FDA Approvals Roundup: Cabenuva, Lupkynis, Verquvo

RAPS.org

Thu, 01/28/21 - 10:49 am

Aurinia snags FDA approval for lupus nephritis med Lupkynis, its first drug launch

Fierce Pharma

Sat, 01/23/21 - 11:46 pm

lupus nephritis